Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
ARTY
Show more
Class 5: Pharmaceutical preparations for the treatment of cancer, viral infections, and tumorous diseases; biological preparations for the treatment of viral infections; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugs, namely, pharmaceutical preparations for the treatment of cancer, viral infections, tumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic …
Class 42: Scientific and technological services, namely, pharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic infl…
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 13 Mar 2021Application filedNew Application Entered
- 4 Oct 2021Assigned to an examining attorneyAssigned To Examiner
- 7 Mar 2022Response to office action filedTeas Response To Office Action Received
- 8 Mar 2022Final refusal issuedFinal Refusal Mailed
- 16 Sep 2022Examination suspendedSuspension Letter Written
- 16 Mar 2023Approved for publicationApproved For Pub - Principal Register
- 25 Apr 2023Published for oppositionPublished For Opposition
- 20 Jun 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 19 Sep 2023Registered on the Principal RegisterRegistered-Principal Register
All 39 events
| 2024-11-20 | Assignment Of Ownership Not Updated Automatically |
| 2023-09-19 | Registered-Principal Register |
| 2023-09-19 | Notice Of Registration Confirmation Emailed |
| 2023-08-10 | Case Assigned To Intent To Use Paralegal |
| 2023-08-10 | 1(B) Basis Deleted; Proceed To Registration |
| 2023-06-20 | Noa Mailed - Sou Required From Applicant |
| 2023-06-20 | Teas Delete 1(B) Basis Received |
| 2023-06-20 | Notice Of Allowance Cancelled |
| 2023-04-25 | Published For Opposition |
| 2023-04-25 | Official Gazette Publication Confirmation E-Mailed |
| 2023-04-05 | Notification Of Notice Of Publication E-Mailed |
| 2023-03-22 | Electronic Record Review Complete |
| 2023-03-20 | Exparte Appeal Terminated |
| 2023-03-17 | On Hold - Electronic Record Review Required |
| 2023-03-16 | Approved For Pub - Principal Register |
| 2022-12-28 | Assignment Of Ownership Not Updated Automatically |
| 2022-09-16 | Suspension Letter Written |
| 2022-09-16 | Letter Of Suspension E-Mailed |
| 2022-09-16 | Notification Of Letter Of Suspension E-Mailed |
| 2022-09-08 | Exparte Appeal Received At Ttab |
| 2022-09-08 | Jurisdiction Restored To Examining Attorney |
| 2022-09-08 | Ex Parte Appeal-Instituted |
| 2022-09-08 | Teas Request For Reconsideration Received |
| 2022-03-08 | Final Refusal Mailed |
| 2022-03-08 | Final Refusal E-Mailed |
| 2022-03-08 | Notification Of Final Refusal Emailed |
| 2022-03-07 | Teas Response To Office Action Received |
| 2022-03-07 | Correspondence Received In Law Office |
| 2022-03-07 | Teas/Email Correspondence Entered |
| 2021-10-06 | Examiners Amendment And/Or Priority Action - Completed |
| 2021-10-06 | Combined Examiner's Amendment/Priority Action Automatic Entry |
| 2021-10-06 | Examiner's Amendment/Priority Action E-Mailed |
| 2021-10-06 | Notification Of Examiner's Amendment/Priority Action E-Mailed |
| 2021-10-04 | Assigned To Examiner |
| 2021-06-24 | Preliminary/Voluntary Amendment - Entered |
| 2021-06-17 | Assigned To Lie |
| 2021-06-10 | New Application Office Supplied Data Entered |
| 2021-03-29 | Teas Voluntary Amendment Received |
| 2021-03-13 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of cancer, viral infections, and tumorous diseases; biological preparations for the treatment of viral infections; biological preparations for medical use for the treatment of tumorous diseases; immunotherapeutic drugs, namely, pharmaceutical preparations for the treatment of cancer, viral infections, tumorous diseases; reagents for medical use; diagnostic preparations for medical purposes; diagnostic reagents for medical use; medical diagnostic reagents used in connection with drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; medical diagnostic …
Class 42 Technology & SaaS
Scientific and technological services, namely, pharmaceutical research and design relating thereto; pharmaceutical research and development services; pharmaceutical testing and clinical trials; research and development in the biotechnology field; drug discovery, namely, the identification of pharmaceutical targets and the development of molecules to be used for medicinal or therapeutic purposes; protein engineering and biological drug development; provision of information and consultancy in relation to the aforesaid services; all of the foregoing excluding treatment of osteoarticular disorders, of bone and joint pathologies, of musculoskeletal pathologies and of degenerative and chronic infl…
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 19 Sep 2023; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.